{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:51:10Z","timestamp":1790682670178,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.idc.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T16:18:05Z","timestamp":1432052285000},"page":"325-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Chronic Lyme Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Paul M.","family":"Lantos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.idc.2015.02.006_bib1","first-page":"S153","article-title":"Lyme borreliose: diagnostic, therapeutic and preventive approaches\u2013long text","volume":"37","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise","year":"2007","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.idc.2015.02.006_bib2","unstructured":"Neuroborreliose. Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie. [Neuroborreliosis: Guidelines of the German Society for Neurology]. Leitlinien-Register. 2008;Nr 030\/071."},{"key":"10.1016\/j.idc.2015.02.006_bib3","first-page":"12","article-title":"Drug treatment of Lyme disease: new recommendation","volume":"4","author":"L\u00e4kemedelsbehandling av borreliainfektion \u2013 ny rekommendation","year":"2009","journal-title":"Inf Fr\u00e5n L\u00e4kemedelsverket"},{"key":"10.1016\/j.idc.2015.02.006_bib4","unstructured":"Kutane Manifestationen der Lyme Borreliose. Leitlinien der Deutschen Dermatologischen Gesellschaft, Arbeitsgemeinschaft f\u00fcr Dermatologische Infektiologie [Cutaneous manifestations of Lyme borreliosis. Guidelines of the German Society of Dermatology, Dermatologic Association for Infectious Diseases]. Leitlinien-Register. 2009;Nr 013\/044."},{"key":"10.1016\/j.idc.2015.02.006_bib5","series-title":"Red Book 2012 report of the committee on infectious diseases","author":"Pickering","year":"2012"},{"issue":"34","key":"10.1016\/j.idc.2015.02.006_bib6","first-page":"2805","article-title":"Laboratory diagnosis of infection caused by Borrelia burgdorferi","volume":"168","author":"Dessau","year":"2006","journal-title":"Ugeskr Laeger"},{"issue":"60","key":"10.1016\/j.idc.2015.02.006_bib7","first-page":"919","article-title":"Lyme disease part I: epidemiology and diagnosis","volume":"2","author":"Evison","year":"2006","journal-title":"Rev Med Suisse"},{"issue":"60","key":"10.1016\/j.idc.2015.02.006_bib8","first-page":"925","article-title":"Lyme disease part 2: clinic and treatment","volume":"2","author":"Evison","year":"2006","journal-title":"Rev Med Suisse"},{"issue":"60","key":"10.1016\/j.idc.2015.02.006_bib9","first-page":"935","article-title":"Lyme disease part 3: prevention, pregnancy, immunodeficient state, post-Lyme disease syndrome","volume":"2","author":"Evison","year":"2006","journal-title":"Rev Med Suisse"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib10","first-page":"193","article-title":"Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases","volume":"62","author":"Flisiak","year":"2008","journal-title":"Przegl Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/654809","article-title":"Final report of the Lyme disease review panel of the Infectious Diseases Society of America","volume":"51","author":"Lantos","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2015.02.006_bib13","first-page":"1175","article-title":"Lyme borreliosis in adults","volume":"128","author":"Ljostad","year":"2008","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.idc.2015.02.006_bib15","unstructured":"O'Connell S, editor. Recommendations for the diagnosis and treatment of Lyme borreliosis: guidelines and consensus papers from specialist societies and expert groups in Europe and North America. Federation of Infections Societies (FIS) \u201cInfection 2009\u201d. Birmingham (United Kingdom): 2009."},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib16","first-page":"605","article-title":"Diagnostics and treatment of Lyme borreliosis","volume":"116","author":"Oksi","year":"2000","journal-title":"Duodecim"},{"issue":"14","key":"10.1016\/j.idc.2015.02.006_bib17","first-page":"659","article-title":"Guideline 'Lyme borreliosis'","volume":"148","author":"Speelman","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"22\u201323","key":"10.1016\/j.idc.2015.02.006_bib18","first-page":"911","article-title":"Principles of the diagnosis and antibiotic treatment of Lyme borreliosis","volume":"111","author":"Strle","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1529-8019.2008.00177.x","article-title":"Lyme borreliosis treatment","volume":"21","author":"Vanousova","year":"2008","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.idc.2015.02.006_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.idc.2015.02.006_bib21","first-page":"741","article-title":"European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis","volume":"108","author":"Stanek","year":"1996","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpeds.2010.06.031","article-title":"Chronic Lyme disease: a survey of Connecticut primary care physicians","volume":"157","author":"Johnson","year":"2010","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1542\/peds.108.6.1367","article-title":"Management of tick bites and early Lyme disease: a survey of Connecticut physicians","volume":"108","author":"Murray","year":"2001","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2015.02.006_bib24","first-page":"S1","article-title":"Evidence-based guidelines for the management of Lyme disease","volume":"2","author":"Cameron","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","article-title":"Summary of the first 100 patients seen at a Lyme disease referral center","volume":"88","author":"Sigal","year":"1990","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.idc.2015.02.006_bib27","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.1993.03500140064037","article-title":"The overdiagnosis of Lyme disease","volume":"269","author":"Steere","year":"1993","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2015.02.006_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjmed.2009.02.022","article-title":"Psychiatric comorbidity and other psychological factors in patients with \u201cchronic Lyme disease\u201d","volume":"122","author":"Hassett","year":"2009","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006454-200201000-00003","article-title":"Overdiagnosis and overtreatment of Lyme disease in children","volume":"21","author":"Qureshi","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.idc.2015.02.006_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/000992289403301105","article-title":"The overdiagnosis of Lyme disease in children residing in an endemic area","volume":"33","author":"Rose","year":"1994","journal-title":"Clin Pediatr"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","article-title":"The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2013the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic","volume":"18","author":"Djukic","year":"2011","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2015.02.006_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7326\/0003-4819-127-12-199712150-00011","article-title":"Laboratory evaluation in the diagnosis of Lyme disease","volume":"127","author":"Tugwell","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0934-8840(11)80304-X","article-title":"A\u00a0Lyme borreliosis human serosurvey of asymptomatic adults in Ireland","volume":"275","author":"Smith","year":"1991","journal-title":"Zentralbl Bakteriol"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1051\/parasite\/1998054383","article-title":"Longitudinal study of Lyme borreliosis in a high risk population in Switzerland","volume":"5","author":"Zhioua","year":"1998","journal-title":"Parasite"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/376914","article-title":"Asymptomatic infection with Borrelia burgdorferi","volume":"37","author":"Steere","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/infdis\/163.2.305","article-title":"The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk","volume":"163","author":"Fahrer","year":"1991","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00365549009027051","article-title":"Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population","volume":"22","author":"Gustafson","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/infdis\/154.2.295","article-title":"Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population","volume":"154","author":"Steere","year":"1986","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2015.02.006_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10096-007-0342-0","article-title":"Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome","volume":"26","author":"Seidel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2015.02.006_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.NPR.0000383661.45156.09","article-title":"Lyme disease: a diagnostic dilemma","volume":"35","author":"Savely","year":"2010","journal-title":"Nurse Pract"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clineuro.2010.11.017","article-title":"'Rare' infections mimicking multiple sclerosis: consider Lyme disease","volume":"113","author":"Stricker","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.mehy.2004.09.011","article-title":"Chronic Lyme borreliosis at the root of multiple sclerosis\u2013is a cure with antibiotics attainable?","volume":"64","author":"Fritzsche","year":"2005","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.idc.2015.02.006_bib45","first-page":"1","article-title":"Surveillance for Lyme disease\u2013United States, 1992-2006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"issue":"11","key":"10.1016\/j.idc.2015.02.006_bib46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7326\/0003-4819-130-11-199906010-00016","article-title":"Functional somatic syndromes","volume":"130","author":"Barsky","year":"1999","journal-title":"Ann Intern Med"},{"issue":"7653","key":"10.1016\/j.idc.2015.02.006_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.39554.592014.BE","article-title":"Assessment and management of medically unexplained symptoms","volume":"336","author":"Hatcher","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11606-006-0067-2","article-title":"Classification and diagnosis of patients with medically unexplained symptoms","volume":"22","author":"Smith","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-117-4-281","article-title":"Lyme disease associated with fibromyalgia","volume":"117","author":"Dinerman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2015.02.006_bib50","article-title":"Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease","author":"Wormser","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","article-title":"Long-term assessment of fatigue in patients with culture-confirmed Lyme disease","volume":"128","author":"Wormser","year":"2014","journal-title":"Am J Med"},{"issue":"7568","key":"10.1016\/j.idc.2015.02.006_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tim.2007.06.003","article-title":"Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix","volume":"15","author":"Cabello","year":"2007","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib54","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cit810","article-title":"A\u00a0systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease","volume":"58","author":"Lantos","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2015.02.006_bib55","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1096\/fj.10-1202LTR","article-title":"The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterprise","volume":"24","author":"Stricker","year":"2010","journal-title":"FASEB J"},{"issue":"7628","key":"10.1016\/j.idc.2015.02.006_bib56","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bmj.39394.676227.BE","article-title":"Lyme wars: let's tackle the testing","volume":"335","author":"Stricker","year":"2007","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.idc.2015.02.006_bib57","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A\u00a0randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.idc.2015.02.006_bib59","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and Treatment Of Post Lyme Disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.idc.2015.02.006_bib60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study","volume":"58","author":"Marques","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib61","first-page":"111","article-title":"Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease","volume":"9","author":"Stricker","year":"2002","journal-title":"Ann Agric Environ Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00316-3","article-title":"Decreased CD57 lymphocyte subset in patients with chronic Lyme disease","volume":"76","author":"Stricker","year":"2001","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib63","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF02770837","article-title":"A\u00a0proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated","volume":"26","author":"Phillips","year":"1998","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01716077","article-title":"Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases","volume":"24","author":"Bayer","year":"1996","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7150\/ijms.5698","article-title":"Improved culture conditions for the growth and detection of Borrelia from human serum","volume":"10","author":"Sapi","year":"2013","journal-title":"Int J Med Sci"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/CVI.00167-09","article-title":"Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls","volume":"16","author":"Marques","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib67","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/CDLI.12.8.910-917.2005","article-title":"Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis","volume":"12","author":"Rauter","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.idc.2015.02.006_bib68","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/JCM.38.11.4239-4241.2000","article-title":"Evaluation of a new culture medium for Borrelia burgdorferi","volume":"38","author":"Marques","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2015.02.006_bib69","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/JCM.39.7.2747.2001","article-title":"Culture Borrelia burgdorferi","volume":"39","author":"Tilton","year":"2001","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.01674-13","article-title":"Assessment of new culture method for detection of Borrelia species from serum of Lyme disease patients","volume":"52","author":"Johnson","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib71","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.mehy.2006.03.046","article-title":"Is Lyme disease always poly microbial?\u2013The jigsaw hypothesis","volume":"67","author":"Owen","year":"2006","journal-title":"Med Hypotheses"},{"issue":"9","key":"10.1016\/j.idc.2015.02.006_bib72","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/378893","article-title":"Coinfection in patients with Lyme disease: how big a risk?","volume":"37","author":"Stricker","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2015.02.006_bib73","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.amjmed.2014.05.036","article-title":"Chronic coinfections in patients diagnosed with chronic Lyme disease: a systematic literature review","volume":"127","author":"Lantos","year":"2014","journal-title":"Am J Med"},{"issue":"21","key":"10.1016\/j.idc.2015.02.006_bib74","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.idc.2015.02.006_bib75","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease: do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib76","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib77","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib78","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(94)90068-X","article-title":"Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management","volume":"96","author":"Sigal","year":"1994","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib79","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s150100050069","article-title":"Comparison of azithromycin and doxycycline in the treatment of erythema migrans","volume":"28","author":"Barsic","year":"2000","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.idc.2015.02.006_bib83","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group","volume":"335","author":"Gerber","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib84","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.idc.2015.02.006_bib86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans","volume":"136","author":"Smith","year":"2002","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2015.02.006_bib87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib88","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area","volume":"50","author":"Kowalski","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-123-2-199507150-00001","article-title":"Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system","volume":"123","author":"Buchwald","year":"1995","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0091-7435(86)90037-X","article-title":"The epidemiology of self-perceived fatigue among adults","volume":"15","author":"Chen","year":"1986","journal-title":"Prev Med"},{"issue":"11","key":"10.1016\/j.idc.2015.02.006_bib91","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","article-title":"Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index","volume":"43","author":"Luo","year":"2005","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib92","first-page":"710","article-title":"The prevalence of chronic widespread pain in the general population","volume":"20","author":"Croft","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib93","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10-20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2015.02.006_bib94","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.idc.2015.02.006_bib95","first-page":"282","article-title":"Memory functioning in Lyme borreliosis","volume":"57","author":"Ravdin","year":"1996","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040910","article-title":"Lyme encephalopathy: a neuropsychological perspective","volume":"17","author":"Kaplan","year":"1997","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib97","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1378\/chest.130.4.1165","article-title":"Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia","volume":"130","author":"El Moussaoui","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-93-1-1","article-title":"Antibiotic therapy in Lyme disease","volume":"93","author":"Steere","year":"1980","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.idc.2015.02.006_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01641422","article-title":"A\u00a0randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis","volume":"18","author":"Weber","year":"1990","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib101","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"11\u201312","key":"10.1016\/j.idc.2015.02.006_bib102","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A\u00a0comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib103","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.02.006_bib104","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/CVI.00002-11","article-title":"Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome","volume":"18","author":"Chandra","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.idc.2015.02.006_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J\u00a0Neuroinflammation"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2169\/internalmedicine.43.49","article-title":"Improvement of chronic nonspecific symptoms by long-term minocycline treatment in Japanese patients with Coxiella burnetii infection considered to have post-Q fever fatigue syndrome","volume":"43","author":"Arashima","year":"2004","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2015.02.006_bib107","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.1990.00040031677015","article-title":"Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial","volume":"150","author":"Caperton","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2015.02.006_bib108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1479-5876-4-34","article-title":"Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data","volume":"4","author":"Vermeulen","year":"2006","journal-title":"J\u00a0Transl Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.006_bib109","first-page":"1","article-title":"Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease","volume":"101","author":"Stricker","year":"2010","journal-title":"Minerva Med"},{"issue":"10","key":"10.1016\/j.idc.2015.02.006_bib110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00007611-199110000-00024","article-title":"Life-threatening complications of empiric ceftriaxone therapy for 'seronegative Lyme disease'","volume":"84","author":"Nadelman","year":"1991","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.idc.2015.02.006_bib111","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/654808","article-title":"Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected Lyme disease","volume":"51","author":"Holzbauer","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.02.006_bib112","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/318138","article-title":"Death from inappropriate therapy for Lyme disease","volume":"31","author":"Patel","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T10:28:00Z","timestamp":1599042480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552015000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0891552015000203"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2015.02.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Lyme Disease","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}